Jae-Hong Park, New President of Research and Development (R&D) Division at Dong-A ST

Jae-Hong Park, New President of Research and Development (R&D) Division at Dong-A ST

View original image

[Asia Economy Reporter Lee Chun-hee] Dong-A ST announced on the 8th that it has recruited President Park Jae-hong as the head of the research and development (R&D) division to achieve its goal of becoming a global leading company.


President Park holds a bachelor's degree in Biotechnology and a master's degree from Yonsei University, and earned his Ph.D. from Boston University School of Medicine in the United States. Since then, he has led innovative new drug development as a translational research expert at prominent global pharmaceutical companies. He has served as head of the Janssen Oncology Translational Research Team, head of Translational Research and Early Clinical Development at Takeda Pharmaceutical, and executive director of Translational Medicine and Clinical Pharmacology at Boehringer Ingelheim.



The company stated, "President Park will lead the discovery and establishment of new growth engines in Dong-A ST's R&D division and strengthen mid- to long-term R&D capabilities."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing